Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dr Khalid Khan, MBBS
Khyber Medical University Peshawar
Principal Investigator - Dr Kinza Ayaz, MBBS
Khyber Medical University Peshawar
Principal Investigator - Dr. Muhammad Tariq Masood Khan, MBBS
Khyber Medical University Peshawar
Principal Investigator - Prof. Dr. Yasar M Yousafzai, PhD
Khyber Medical University Peshawar
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hayatabad Medical Complex
Peshawar, KPK, Pakistan
- Institute of Pathology and Diagnostic Medicine (ipdm)
Peshawar, KPK, Pakistan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Sept 2025
- Primary completion
- 28 Mar 2026
- Completion
- 15 Apr 2026
- Last update posted
- 25 Jun 2026
- Registered enrollment
- 18
- Registry id
- NCT07187661
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.